8-KFiled Aug 9, 8:00 PM ET

Fractyl Health Reports Results for Quarter Ended June 30, 2026

$GUTS · FRACTYL HEALTH, INC.

Research Summary

AI-generated summary of this SEC filing

Updated

Fractyl Health Reports Results for Quarter Ended June 30, 2026

What Happened
On August 10, 2026, Fractyl Health, Inc. (GUTS) announced its financial results for the quarter ended June 30, 2026 and provided a corporate update. The company furnished a press release connected with the announcement as Exhibit 99.1 to its Current Report on Form 8-K. The filing was signed by Co‑Founder and CEO Harith Rajagopalan, M.D., Ph.D.

Key Details

  • Filing date: August 10, 2026 (Form 8-K, Item 2.02).
  • Reporting period: quarter ended June 30, 2026 (quarterly results / earnings announcement).
  • Press release furnished as Exhibit 99.1 (the information was furnished, not filed).
  • Form signed by CEO Harith Rajagopalan, M.D., Ph.D.

Why It Matters
Fractyl’s 8-K signals the company has released its latest quarterly results and a corporate update; investors should review the attached press release for concrete financial metrics (revenue, net loss, cash position, guidance) that could affect the stock. Because the report furnishes—rather than files—the press release, the 8-K provides timely disclosure but does not include additional formal financial statements beyond the press release itself.